Thus, so far little is known about the full extent of CFTR modulator’s effects on CF pathogens as well as on the long-term effects on chronic airway infections and infectious exacerbations, and some inconsistent results have been reported. The gene discussed is CFTR; the disease is cystic fibrosis.